News
Catch up on our latest updates
Innovation is one of the pillars of Eclipsebio’s culture, and our team of RNA experts is always developing new technologies and solutions. Learn more about our latest breakthroughs below.
Eclipsebio Expands eMERGE™ Platform with eSENSE dsRNA™ for dsRNA Quantification and Localization
SAN DIEGO, September 3, 2024 — Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in developing precision solutions for RNA-based and RNA-targeting therapeutics, today announced the launch of its eSENSE dsRNA™ assay. eSENSE dsRNA is a next-generation sequencing method for the robust quantification, localization, and optimization of double-stranded RNA (dsRNA) contaminants in RNA-based vaccines and therapeutics. “By […]
RNA and AI Symposium 2024
Eclipsebio is proud to announce their sponsorship of RNA UK 2024, the premier event for bringing experts in RNA biology together to discuss the latest RNA discoveries.
Mechanisms of RNA Decay 2024
Eclipsebio is proud to announce their sponsorship of RNA UK 2024, the premier event for bringing experts in RNA biology together to discuss the latest RNA discoveries.
Eclipsebio Launches eMERGE™ Platform, a Cutting-Edge End-to-End Solution for the Characterization and Optimization of RNA-Based Therapeutic Products
Eclipse Bioinnovations, Inc. (Eclipsebio), the leading RNA genomics company developing and commercializing novel, data-driven technologies and analyses that interrogate RNA, today announced the launch of its proprietary eMERGE™ platform.
RNA UK 2024
Eclipsebio is proud to announce their sponsorship of RNA UK 2024, the premier event for bringing experts in RNA biology together to discuss the latest RNA discoveries.
Eclipsebio Launches eRibo Pro™, a Ribosome Profiling Service to Obtain RNA Translation Data
Eclipsebio, a leading provider of innovative RNA analysis solutions, announces the launch of its proprietary eRibo Pro™ service, an all-inclusive offering to identify differential transcription and translation as well as ribosome positioning. The launch of eRibo Pro™ marks an important milestone in Eclipsebio's mission to accelerate the development of tomorrow’s key RNA genomics discoveries & medicines by providing researchers with tools to interrogate the complexity of RNA.